NTI Recorded Session NTI26293
Author(s): Richard Arbour, MSN,RN,CCRN,CNRN,CCNS,CCTC,FAAN,FCCM; Orion L Garcia, RN BSN CCRN; Mackenzie Abate, DNP, CRNP
Contact Hours 2.50
CERP A 2.50
Pharmacology Hours 0.50
Expires Dec 31, 2028
Topics: Pharmacology, ECMO
Population: Adult
Role: APRN, Staff
Before you Begin
1. Reflect on the following question: What new knowledge or perspective do you hope to gain from this activity?
2. Review: Implicit Bias and its Impact on Patient Outcomes (License requirement for California)
Description
Session includes ECMO indications/contraindications, interfacility referral criteria and differentiation of flow versus sweep speed. Real-time titration is appraised in V-A/V-V ECMO for goal-directed care, brain death testing and ethical analysis of patient selection/criteria for nonbeneficial care in ECMO palliation and death. Advanced case studies analyze ECMO deescalation/decannulation in the setting of nonbeneficial care, sweep titration in CO2 responsiveness/apnea testing, goal-directed care with patient-specific ECMO titration and defining death while accenting interdisciplinary care and APRN roles. Pharmacology content = 20%Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.
AccreditationAmerican Association of Critical-Care Nurses is accredited as a provider of
nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for
{contactHours} contact hours.
The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.
Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.
Refund PolicyContinuing Education Activities are nonrefundable.